Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection
ConclusionsAn 8- or 12-week G/P regimen is highly effective and safe in GT2 HCV-infected hemodialysis patients.
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research
More News: Cirrhosis | Clinical Trials | Dialysis | Gastroenterology | Hemodialysis | Hepatitis | Hepatitis C | Japan Health | Liver | Study | Urology & Nephrology | Virology